33 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 35039480 | Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer. | 2022 Jan 17 | 1 | ||
2 | 33079733 | Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies. | 2021 Jan 1 | 1 | ||
3 | 34893686 | FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11. | 2021 Dec 10 | 1 | ||
4 | 30332940 | Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents. | 2020 | 1 | ||
5 | 30651077 | Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells. | 2019 Jan 16 | 1 | ||
6 | 28972015 | Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients. | 2017 Nov 9 | 1 | ||
7 | 26827693 | The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies. | 2016 Feb | 1 | ||
8 | 27318982 | Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors. | 2016 Oct 4 | 2 | ||
9 | 27470351 | Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. | 2016 Aug | 4 | ||
10 | 26043217 | Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma. | 2015 | 1 | ||
11 | 26053117 | Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage. | 2015 Aug | 1 | ||
12 | 18821579 | Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation. | 2009 Jan 1 | 3 | ||
13 | 18971205 | Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. | 2009 Jan 15 | 3 | ||
14 | 19200053 | The changing face of HDAC inhibitor depsipeptide. | 2009 Feb | 2 | ||
15 | 19322073 | Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. | 2009 Jun | 2 | ||
16 | 18416310 | Histone deacetylase inhibitors from microorganisms: the Astellas experience. | 2008 | 2 | ||
17 | 17671692 | The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. | 2007 Sep | 2 | ||
18 | 16186804 | Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma. | 2006 Jan 26 | 2 | ||
19 | 16418572 | Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice. | 2006 Mar | 2 | ||
20 | 16424655 | Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib. | 2006 | 2 | ||
21 | 16435156 | FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities. | 2006 Nov | 1 | ||
22 | 16888791 | Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin. | 2006 Dec | 1 | ||
23 | 15515013 | Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). | 2005 May | 2 | ||
24 | 15791453 | Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. | 2005 Jul | 3 | ||
25 | 15833893 | Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines. | 2005 Jul | 1 | ||
26 | 15914281 | Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. | 2005 Jun 28 | 4 | ||
27 | 15063388 | Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. | 2004 Jul | 2 | ||
28 | 15078940 | Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. | 2004 May | 3 | ||
29 | 15171260 | Histone deacetylase inhibitors: development as cancer therapy. | 2004 | 1 | ||
30 | 12569581 | Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. | 2003 Mar 20 | 3 | ||
31 | 12642691 | The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. | 2002 Nov-Dec | 3 | ||
32 | 12678732 | Histone deacetylase inhibitors and anticancer therapy. | 2002 Jul | 2 | ||
33 | 11443220 | Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. | 2001 Jul | 3 |